News Xlife Sciences AG BOERSE MUENCHEN

Equities

XLS

CH0461929603

Market Closed - BOERSE MUENCHEN Other stock markets 18:43:00 10/02/2022 GMT			5-day change	1st Jan Change
41.8 ^EUR	-0.48%		-7.52%	-3.69%

04-23	Xlife Sciences Posts Higher FY23 Profit; Revenue Falls	MT
02-29	Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xlife Sciences Posts Higher FY23 Profit; Revenue Falls	04-23	MT
Xlife Sciences AG Publishes 2023 Annual Report	04-23	EQ
Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland	04-03	EQ
Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Switzerland’s Xlife Sciences, Abu Dhabi Expand Existing Life Sciences Partnership	02-05	MT
Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City	02-05	EQ
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline	12-29	EQ
Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases	12-22	EQ
Xlife Sciences, Quant Team Up to Develop Biomarkers for Kidney Diseases Detection	12-20	MT
Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases	12-20	EQ
Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration	12-18	EQ
Xlife Sciences to Sell Portfolio Company to 4D Lifetec	18/10/23	MT
Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million	18/10/23	EQ
Xlife Sciences AG acquired 20% stake in 4D Lifetec AG for CHF 23.3 million.	17/10/23	CI
ESG Report shows status quo and outlines path for future sustainability improvements Media Release Zurich, September 29, 2023	29/09/23	EQ
Xlife Sciences Loss Narrows in H1; Revenue Declines	21/09/23	MT
Xlife Sciences with significant progress in H1 2023	21/09/23	EQ
Xlife Sciences AG Reports Earnings Results for the Half Year Ended June 30, 2023	20/09/23	CI
Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector	17/08/23	EQ
Xlife Sciences AG Signs Memorandum of Understanding with the Regulator of the Healthcare Sector in the UAE, the Department of Health - Abu Dhabi	17/08/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Xlife Sciences AG BOERSE MUENCHEN

Equities

XLS

CH0461929603

Summary

Filters